Problems and potential for gene therapy in Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 7, Issue 5, 1997, Pages 319-324

  Kakulas, B A ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Duchenne muscular dystrophy; Gene therapy; Problems and potential

Indexed keywords

DYSTROPHIN;

BECKER MUSCULAR DYSTROPHY; BREATHING MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENETIC COMPLEMENTATION; HEART INJURY; HUMAN; LIFE EXPECTANCY; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYOBLAST; PRIORITY JOURNAL; REVIEW;

EID: 0030776795     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00056-4     Document Type: Article

References (33)

1. Cummings MR. Human Heredity, Principles and Issues. St. Paul, MN: West Publishing Co, 1991.
2. Emery AEH. Duchenne Muscular Dystrophy, 2nd edn. Oxford: Oxford Medical Publications, 1993.
3. Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ, Caskey CT. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 1989;465-474.
4. Gardner-Medwin D. Recognising and preventing Duchenne muscular dystrophies. Br Med J 1983;287:1083-1084.
5. Vassilopoulos D, Emery AEH. Muscle nuclear changes in foetuses at risk for Duchenne muscular dystrophy. J Med Genet 1977;14:13-15.
6. Vassilopoulos D, Lumb EM, Emery AEH. Muscle nuclear size in neuromuscular disease. J Neurol Neurosurg Psychiatry 1976;39:159-162.
7. Mahoney MJ, Haseltine FP, Hobbins JC, Banker BQ, Caskey CT, Golbus MS. Prenatal diagnosis of Duchenne's muscular dystrophy. N Engl J Med 1977;18:968-973.
8. Emery AEH. Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 1977;266:472-473.
9. Kakulas BA. Early pathologic changes in Duchenne muscular dystrophy. Proceedings of the XIth International Congress of Neuropathology, Kyoto, September 2-8 1990. Yonezawa T, ed. Neuropathology Suppl. 4. The Japanese Society of Neuropathology 1991:543.
10. Emery AEH, Burt D. Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J 1980;284:355-357.
11. Bradley WG, Hudgson P, Larson PF, Papapetropoulos TA, Jenkison M. Structural changes in the early stages of Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 1972;35:451-455.
12. Hudgson P, Pearce GW, Walton JN. Preclinical muscular dystrophy: histopathological changes observed on muscle biopsy. Brain 1967;90:565-576.
13. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
14. Fidzianska A, Hoebel HH, Kosswig R, Burck U. 'Killer' cells in Duchenne disease: ultrastructural study. Neurology 1984;34:295-303.
15. Mastaglia FL, Kakulas BA. Regeneration in Duchenne muscular dystrophy: a histological and histochemical study. Brain 1969;92:809-818.
16. Mastaglia FL, Papadimitriou JM, Kakulas BA. Regeneration of muscle in Duchenne muscular dystrophy. An electron microscopic study. J Neurol Sci 1970;11:425-444.
17. Kakulas BA, Guo YP. Quantitative assessment of muscle lesions in 19 Duchenne necropsies. Muscle Nerve 1986; 9 (No 5S, Suppl): 206 (abstract 39.23).
18. Kakulas BA, Adams RD. Diseases of the Muscle. Pathological Foundations of Clinical Myology, 4th Edition. Philadelphia: Harper and Row, 1985.
19. Mokri B, Engel AG. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fibre. Neurology 1975;25:1111-1120.
20. Cullen MJ, Mastaglia FL. Morphological changes in dystrophic muscles. Br Med Bull 1980;36:145-152.
21. Mastaglia FL, Kakulas BA. The natural history of human muscle diseases studied by means of serial biopsy. Proc Aust Assoc Neurol 1968;5:537-543.
22. Papadimitriou JM, Kakulas BA. Ultrastructure of skeletal muscle in muscular dystrophy, the carrier state and other human myopathies. Proc Aust Assoc Neural 1968;5:87-94.
23. Papadimitriou JM, Mastaglia FL, Kakulas BA. The natural history of Duchenne muscular dystrophy: an ultrastructural study. Proc Aust Assoc Neurol 1969;6:87-92.
24. Cullen MJ, Fulthorpe JJ. Stages in fibre break-down in Duchenne dystrophy. An electron microscopic study. J Neural Sci 1975;24:179-200.
25. Wakayama Y, Okayasu H, Shibuya S, Kumagai T. Duchenne dystrophy: reduced density of orthogonal array subunit particles in muscle plasma membrane. Neurology 1984;34:1313.
26. Rosman NP, Kakulas BA. Mental deficiency associated with muscular dystrophy: a neuropathological study. Brain 1966;89:769-788.
27. Dubowitz V, Crome L. The central nervous system in Duchenne muscular dystrophy. Brain 1969;92:805-808.
28. Kakulas BA, Adams RD. Principles of myopathology as illustrated in the nutritional myopathy of the Rottnest Island Quokka (Setonix brachyurus). Ann N Y Acad Sci 1966;138:90-101.
29. Kakulas BA. The Investigation of Muscular Paralysis occurring in the Rottnest Island Quokka (Setonix brachyurus). Man, Marsupial and Muscle. University of Western Australia Press, 1982.
30. Kakulas BA, Mastaglia FL. Pathogenesis and Therapy of Duchenne Muscular Dystrophy. New York: Raven Press, 1990.
31. Blake DJ, Tinsley JM and Davies KE. Utrophin: a structural and functional comparison to Dystrophin. Brain Pathol 1996;6:37-47.
32. Dominski Z, Kole R. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc Natl Acad Sci USA 1993;90:8673-8677.
33. Campbell KP, Crosbie RH. Utrophin to the rescue. Nature 1996;384:308-309.